ArticleFrontiers in bioinformatics2026
Machine learning identifies molecular targets of Di (2-ethylhexyl) phthalate in pulmonary arterial hypertension.
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring the Toxicological Impacts of DOTP Exposure on Pulmonary Arterial Hypertension via Network Toxicology, Virtual Knockout, Molecular Docking and Experimental Validation.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to explore the potential molecular mechanisms by which di (2-ethylhexyl) phthalate (DEHP) exposure induces pulmonary arterial hypertension (PAH). Methods: We conducted differential expression analysis on multiple genomics datasets to pinpoint PAH-associated genes. Subsequently, an integrative approach combining machine learning algorithms and network toxicology was employed to examine the binding interactions between DEHP and the identified target proteins. Results: Our analysis identified 60 genes as potential targets of DEHP in PAH. Further refinement using machine learning prioritized twelve core regulatory genes: ALKBH2, AOC2,BCL2L10,CTBP2,DNM2,ERLIN2,HPS6,RABGGTA,PON2,SLC4A7,SORT1, and PDE4D. Among these, HPS6, CTBP2,RABGGTA, SORT1,ALKBH2,BCL2L10, AOC2,and PON2 were significantly downregulated, whereas SLC4A7,PDE4D, ERLIN2,and DNM2 were markedly upregulated (P < 0.05). Conclusion: These findings demonstrate that DEHP promotes PAH pathogenesis by modulating specific genes and associated pathways. The twelve core genes identified through machine learning are proposed as key regulators in this process, providing crucial insights for future mechanistic investigation into DEHP-induced PAH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.